$3.17 0.0 0.3%
Last Trade - 22/01/21
Market Cap | £5.28m |
Enterprise Value | £805k |
Revenue | £n/a |
Position in Universe | 6152nd / 6630 |
Oct 29 (Reuters) - Cellect Biotechnology Ltd APOP.O : * CELLECT BIOTECHNOLOGY LTD - COMMENCES COLLABORATION WITH XNK THERAPEUTICS TO ADVANCE NOVEL NK CELL-BASED THERAPIES * CELLECT BIOTECHNOLOGY - WILL HELP IMPROVE XNK THERAPEUTICS' TECHNOLOGY PLATFORM, FOR TARGETING CANCER ACROSS A WIDE RANGE OF INDICATIONS * CELLECT BIOTECHNOLOGY LTD - EXPECTS TO EXPAND BUSINESS ARRANGEMENT BASED ON OUTCOMES OF ONGOING STUDIES AT XNK THERAPEUTICS Source text for Eikon: ID:nGNX4g9z54 Further company coverage: APOP.O ((Reuters.Briefs@thomsonreuters.com;))